Loris De Cecco Selected Research

Loris De Cecco Research Topics

Disease

68	Neoplasms (Cancer) 04/2024 - 09/2004
25	Breast Neoplasms (Breast Cancer) 01/2024 - 06/2005
13	Ovarian Neoplasms (Ovarian Cancer) 04/2023 - 10/2004
12	Squamous Cell Carcinoma of Head and Neck 01/2024 - 04/2015
5	Disease Progression 01/2024 - 12/2017
5	Ovarian Epithelial Carcinoma 01/2022 - 07/2015
5	Carcinoma (Carcinomatosis) 01/2020 - 03/2010
5	Carcinogenesis 12/2019 - 10/2004
4	Melanoma (Melanoma, Malignant) 01/2024 - 06/2004
4	Glioma (Gliomas) 06/2023 - 06/2014
4	Head and Neck Neoplasms (Head and Neck Cancer) 10/2022 - 01/2017
3	Neoplasm Metastasis (Metastasis) 02/2023 - 01/2017
3	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 12/2022 - 09/2018
3	Adenocarcinoma of Lung 10/2022 - 06/2009
3	Squamous Cell Neoplasms (Squamous Cell Cancer) 12/2019 - 01/2016
2	Lung Neoplasms (Lung Cancer) 10/2022 - 09/2018
2	Inflammation (Inflammations) 10/2022 - 11/2017
2	Infections 03/2021 - 01/2021
2	Sarcoma (Soft Tissue Sarcoma) 11/2018 - 01/2017
2	Colorectal Neoplasms (Colorectal Cancer) 01/2016 - 01/2013
2	Colonic Neoplasms (Colon Cancer) 01/2016 - 01/2012
1	Medulloblastoma 07/2023
1	Osteosarcoma (Osteogenic Sarcoma) 06/2023
1	Neutropenia 06/2023
1	Stomach Neoplasms (Stomach Cancer) 01/2023
1	Oropharyngeal Neoplasms 12/2022
1	Oncogene Addiction 11/2022
1	Triple Negative Breast Neoplasms 01/2022
1	Circulating Neoplastic Cells 01/2022

Drug/Important Bio-Agent (IBA)

26	MicroRNAs (MicroRNA)IBA 09/2022 - 03/2010
15	Biomarkers (Surrogate Marker)IBA 01/2024 - 11/2009
10	Proteins (Proteins, Gene)FDA Link 01/2024 - 01/2014
9	Estrogen ReceptorsIBA 11/2022 - 06/2005
7	PlatinumIBA 01/2024 - 01/2013
6	Cetuximab (Erbitux)FDA Link 10/2022 - 01/2016
5	Trastuzumab (Herceptin)FDA Link 11/2022 - 09/2015
5	Messenger RNA (mRNA)IBA 11/2022 - 01/2015
5	RNA (Ribonucleic Acid)IBA 01/2022 - 06/2004
4	Phenobarbital (Luminal)FDA Link 01/2023 - 07/2015
4	Complementary DNA (cDNA)IBA 06/2008 - 06/2004
3	Immune Checkpoint InhibitorsIBA 04/2024 - 01/2021
3	VemurafenibIBA 01/2024 - 01/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 02/2023 - 01/2021
3	Poly(ADP-ribose) Polymerase InhibitorsIBA 01/2023 - 07/2015
3	Urethane (Ethyl Carbamate)IBA 11/2017 - 04/2014
3	Cisplatin (Platino)FDA LinkGeneric 07/2015 - 10/2011
3	CPG-oligonucleotideIBA 01/2013 - 10/2011
3	DNA (Deoxyribonucleic Acid)IBA 01/2013 - 10/2011
2	PlasticsIBA 01/2024 - 11/2018
2	NivolumabIBA 01/2024 - 01/2021
2	AntibodiesIBA 01/2024 - 12/2022
2	trametinibIBA 01/2024 - 11/2022
2	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2024 - 01/2019
2	Choline (Choline Chloride)IBA 12/2023 - 01/2021
2	dipinacoline glutamateIBA 06/2023 - 06/2014
2	Complement System Proteins (Complement)IBA 02/2023 - 12/2021
2	Estrogen Receptor alphaIBA 01/2023 - 06/2008
2	olaparibIBA 01/2023 - 07/2015
2	CytokinesIBA 12/2022 - 01/2016
2	Estrogens (Estrogen)FDA Link 11/2022 - 06/2008
2	Long Noncoding RNAIBA 01/2020 - 01/2017
2	Vinorelbine (Navelbine)FDA LinkGeneric 07/2018 - 06/2014
2	nimotuzumabIBA 07/2018 - 06/2014
2	Type 4 Fibroblast Growth Factor ReceptorIBA 06/2009 - 10/2004
2	Estrogen Receptor Modulators (Antiestrogen)IBA 10/2008 - 06/2005
1	Interleukin-8 (Interleukin 8)IBA 01/2024
1	Phosphotransferases (Kinase)IBA 01/2024
1	IpilimumabIBA 01/2024
1	Tramadol (K315)FDA LinkGeneric 01/2024
1	Protons (Proton)IBA 12/2023
1	Methotrexate (Mexate)FDA LinkGeneric 06/2023
1	Bevacizumab (Avastin)FDA Link 04/2023
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 04/2023
1	Ampicillin (Omnipen)FDA LinkGeneric 02/2023
1	Adenosine Monophosphate (AMP)IBA 02/2023
1	16S Ribosomal RNAIBA 02/2023
1	Arginine (L-Arginine)FDA Link 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	2-Oxoglutarate 5-Dioxygenase Procollagen-Lysine (Lysyl Hydroxylase)IBA 01/2023
1	LipidsIBA 12/2022
1	Conditioned Culture MediaIBA 12/2022
1	dabrafenibIBA 11/2022
1	Mechanistic Target of Rapamycin Complex 1IBA 11/2022
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2022
1	MAP Kinase Kinase Kinases (MAP Kinase Kinase Kinase)IBA 11/2022
1	Drug CombinationsIBA 11/2022
1	CarcinogensIBA 10/2022
1	AerosolsIBA 10/2022
1	ErbB Receptors (EGF Receptor)IBA 10/2022
1	Circulating MicroRNAIBA 01/2022
1	Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA 01/2022

Therapy/Procedure

27	Therapeutics 01/2024 - 10/2008
14	Drug Therapy (Chemotherapy) 07/2023 - 10/2011
5	Immunotherapy 04/2024 - 01/2017
4	Neoadjuvant Therapy 01/2022 - 01/2021
3	Re-Irradiation 07/2023 - 06/2014
2	Radiotherapy 12/2022 - 06/2014
2	Aftercare (After-Treatment) 01/2022 - 01/2021
1	Tertiary Prevention 01/2023
1	Salvage Therapy 01/2022